| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/08/1998 | CN1178552A New difined enzyme mixture for obtaining cells and treating wounds |
| 04/08/1998 | CN1178534A Isolated nucleic acid molecules as members of the Mage-Xp family and uses thereof |
| 04/07/1998 | US5736627 Virus resistant plants having coat protein |
| 04/07/1998 | US5736399 Containing natural or synthetic threads |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | US5736395 Transforming cells in mammal by contacting with complexes comprising an expression cassette and a nitrogen-containing amphiphile |
| 04/07/1998 | US5736390 BCRF1 proteins as inhibitors of interferon-γ |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736372 Artificial matrices for growth of bone |
| 04/07/1998 | US5736346 Induction of the acrosome reaction to evaluate the fertilization capability of mammalian sperm using a dendrimer sugar conjugate |
| 04/07/1998 | US5736345 Incubation and culturing |
| 04/07/1998 | US5736317 Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
| 04/07/1998 | US5736142 Alteration of immune response using pan DR-binding peptides |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/02/1998 | WO1998013510A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 04/02/1998 | WO1998013509A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | WO1998013505A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
| 04/02/1998 | WO1998013499A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 04/02/1998 | WO1998013498A1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/02/1998 | WO1998013497A1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013490A2 A gene related to migraine in man |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013478A2 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | WO1998013475A1 Methods for culturing cells |
| 04/02/1998 | WO1998013472A1 Methods for the production of bacteria containing eukaryotic genes |
| 04/02/1998 | WO1998013386A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | WO1998013382A1 A process for culturing cells |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013379A1 METHOD OF CELL INHIBITION USING POLYPEPTIDES DERIVED FROM THE VENOM OF THE AUSTRIALIAN JUMPER ANT $i(MYRMECIA PILOSULA) |
| 04/02/1998 | WO1998013076A1 Cultured cell-seeded fibrous lattice for tissue replacement |
| 04/02/1998 | WO1998013070A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | WO1998012913A1 Expression of globin proteins in plants |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | DE19632404A1 Artificial tissue comprising three-dimensional extracellular matrix, cell interaction system |
| 04/02/1998 | CA2267667A1 Bacillus thuringiensis cryet29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 04/02/1998 | CA2267666A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | CA2267332A1 Methods for culturing cells |
| 04/02/1998 | CA2267221A1 A gene related to migraine in man |
| 04/02/1998 | CA2266905A1 Methods for the production of bacteria containing eukaryotic genes |
| 04/02/1998 | CA2266855A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 04/02/1998 | CA2266744A1 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 04/02/1998 | CA2266626A1 Expression of globin proteins in plants |
| 04/02/1998 | CA2266619A1 Non-invasive administration of adeno-associated viral vectors |
| 04/02/1998 | CA2266427A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | CA2266336A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 04/02/1998 | CA2265519A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs |
| 04/02/1998 | CA2264567A1 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | CA2264546A1 Two human cathepsin proteins |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832980A1 Recombinant therapies for infection and hyperproliferative disorders |
| 04/01/1998 | EP0832978A2 Novel 3-dehydroquinate synthase |
| 04/01/1998 | EP0832976A2 Thermostable DNA polymerase from bacillus pallidus |
| 04/01/1998 | EP0832901A1 Antibodies to hepatitis G virus, and their diagnostic use to detect HGV, and as therapeutic agent |
| 04/01/1998 | EP0832300A1 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832273A1 Synthetic mammalian chromosome and methods for construction |
| 04/01/1998 | EP0832269A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 04/01/1998 | EP0832268A1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
| 04/01/1998 | EP0832262A1 Modification of plant lipids and seed oils utilizing yeast slc genes |
| 04/01/1998 | EP0832261A2 Induction of male sterility in plants by expression of high levels of avidin |
| 04/01/1998 | EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
| 04/01/1998 | EP0832254A1 An autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832244A1 Polyphenol oxidase genes from lettuce and banana |
| 04/01/1998 | EP0832235A1 HIGH METHIONINE DERIVATIVES OF alfa-HORDOTHIONIN |
| 04/01/1998 | EP0832234A2 Genetic control of flowering |
| 04/01/1998 | EP0832233A1 Human chemokine beta-13 |
| 04/01/1998 | EP0832230A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 04/01/1998 | EP0832229A2 Cd40l mutein |
| 04/01/1998 | EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
| 04/01/1998 | EP0832217A1 Modified steroid hormones for gene therapy and methods for their use |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832215A1 Fibroblast growth factor 11 |
| 04/01/1998 | EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
| 04/01/1998 | EP0832212A1 Intergenic regions of banana bunchy top virus |
| 04/01/1998 | EP0832209A1 Secretion leader trap cloning method |
| 04/01/1998 | EP0832207A1 A method for identification of biologically active peptides and nucleic acids |
| 04/01/1998 | EP0832204A1 Treatment of insulin resistance |
| 04/01/1998 | EP0832203A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 04/01/1998 | EP0832202A1 Aav directed targeted integration |
| 04/01/1998 | EP0832199A1 Fucosyltransferase genes and uses thereof |
| 04/01/1998 | EP0832196A1 Immortalization and disimmortalization of cells |
| 04/01/1998 | EP0832195A1 Standardized, primary osteoblast cell cultures taken from patients suffering from osteoporosis, and the use of these cell cultures in the diagnosis of osteoporosis and for testing potential osteoporosis therapeutic agents |
| 04/01/1998 | EP0832194A1 Bile duct progenitor cells and methods of use |
| 04/01/1998 | EP0832193A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function |
| 04/01/1998 | EP0832192A1 Novel cryopreserved hepatocytes and process for doing same |
| 04/01/1998 | EP0832191A1 Recombinant viral nucleic acids |
| 04/01/1998 | EP0832190A1 Essential oligonucleotides of vertebrate telomerase |
| 04/01/1998 | EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 04/01/1998 | EP0832188A1 Chemically defined medium for human mesenchymal stem cells |
| 04/01/1998 | EP0832187A1 Cell differentiation agents |